Our Mission
Our Vision
- Digital twin of patients (in-silico experiments to identify novel drugs)
- Quantum chemical models of cells and pathways to better understand diseases and identify new research directions
- Make disruptive technology actionable to enable robotic laboratory to automatically perform necessary experiments
- Predictive clinical trials for faster study design and significantly higher drug approval rates
- Fully automated and data driven drug submission to allow faster assessment and approval of new innovative drugs
- Fully digital twin to streamline manufacturing of high-quality drugs
- Digital commercialization and patient engagement (Digital Health)